Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 1972429, 7 pages
https://doi.org/10.1155/2017/1972429
Research Article

Existence of HbF Enhancer Haplotypes at HBS1L-MYB Intergenic Region in Transfusion-Dependent Saudi β-Thalassemia Patients

1Department of Genetic Research, Institute for Research and Medical Consultation, University of Dammam, Dammam, Saudi Arabia
2King Fahd Hospital of the University, University of Dammam, Dammam, Saudi Arabia
3Maternity and Children’s Hospital, Dammam, Saudi Arabia
4Al-Omran Scientific Chair for Hematological Diseases, King Faisal University, Maternity and Children’s Hospital, Dammam, Saudi Arabia
5College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia
6Center of Excellence in Sickle Cell Disease, Department of Medicine, Boston University School of Medicine, Boston, MA, USA

Correspondence should be addressed to Cyril Cyrus; as.ude.dou@surycc

Received 9 October 2016; Revised 14 December 2016; Accepted 16 January 2017; Published 9 February 2017

Academic Editor: Milton O. Moraes

Copyright © 2017 Cyril Cyrus et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. I. Ataga, M. D. Cappellini, and E. A. Rachmilewitz, “β-Thalassaemia and sickle cell anaemia as paradigms of hypercoagulability,” British Journal of Haematology, vol. 139, no. 1, pp. 3–13, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. A. K. Al-Ali, S. Al-Ateeq, B. W. Imamwerdi et al., “Molecular bases of β-thalassemia in the Eastern province of Saudi Arabia,” Journal of Biomedicine and Biotechnology, vol. 2005, no. 4, pp. 322–325, 2005. View at Publisher · View at Google Scholar
  3. A. Alsultan, N. Solovieff, A. Aleem et al., “Fetal hemoglobin in sickle cell anemia: Saudi patients from the Southwestern province have similar HBB haplotypes but higher HbF levels than African Americans,” American Journal of Hematology, vol. 86, no. 7, pp. 612–614, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. M. S. Akhtar, F. Qaw, J. Francis Borgio et al., “Spectrum of α-thalassemia mutations in transfusion-dependent β-thalassemia patients from the eastern province of Saudi Arabia,” Hemoglobin, vol. 37, no. 1, pp. 65–73, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. J. F. Borgio, S. AbdulAzeez, A. N. Al-Nafie et al., “A novel HBA2gene conversion in cisor trans: ‘α12 allele’ in a Saudi population,” Blood Cells, Molecules, and Diseases, vol. 53, no. 4, pp. 199–203, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. A. N. Al-Nafie, J. F. Borgio, S. AbdulAzeez et al., “Co-inheritance of novel ATRX gene mutation and globin (α & β) gene mutations in transfusion dependent beta-thalassemia patients,” Blood Cells, Molecules, and Diseases, vol. 55, no. 1, pp. 27–29, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. J. F. Borgio, S. AbdulAzeez, Z. A. Naserullah et al., “Mutations in the β-globin gene from a Saudi population: an update,” International Journal of Laboratory Hematology, vol. 38, no. 2, pp. e38–e40, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. D. A. Ngo and M. H. Steinberg, “Genomic approaches to identifying targets for treating β hemoglobinopathies,” BMC Medical Genomics, vol. 8, no. 1, article 44, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Uda, R. Galanello, S. Sanna et al., “Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of β-thalassemia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 5, pp. 1620–1625, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. B. H. Al-Awamy, “Thalassemia syndromes in Saudi Arabia: meta-analysis of local studies,” Saudi Medical Journal, vol. 21, no. 1, pp. 8–17, 2000. View at Google Scholar · View at Scopus
  11. D. Labie, O. Dunda-Belkhodja, F. Rouabhi, J. Pagnier, A. Ragusa, and R. L. Nagel, “The -158 site 5′ to the G gamma gene and G gamma expression,” Blood, vol. 66, pp. 1463–1465, 1985. View at Google Scholar
  12. N. Solovieff, J. N. Milton, S. W. Hartley et al., “Fetal hemoglobin in sickle cell anemia: genome-wide association studies suggest a regulatory region in the 5′ olfactory receptor gene cluster,” Blood, vol. 115, no. 9, pp. 1815–1822, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Menzel, J. Jiang, N. Silver et al., “The HBS1L-MYB intergenic region on chromosome 6q23.3 influences erythrocyte, platelet, and monocyte counts in humans,” Blood, vol. 110, no. 10, pp. 3624–3626, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. S. L. Thein, S. Menzel, X. Peng et al., “Intergenic variants of HBS1L-MYB are responsible for a major quantitative trait locus on chromosome 6q23 influencing fetal hemoglobin levels in adults,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 27, pp. 11346–11351, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Galarneau, C. D. Palmer, V. G. Sankaran, S. H. Orkin, J. N. Hirschhorn, and G. Lettre, “Fine-mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation,” Nature Genetics, vol. 42, no. 12, pp. 1049–1051, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Borg, P. Papadopoulos, M. Georgitsi et al., “Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobin,” Nature Genetics, vol. 42, no. 9, pp. 801–807, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. V. Vinod, J. J. Farrell, S. Wang et al., “A candidate trans-acting modulator of fetal hemoglobin gene expression in the Arab-Indian haplotype of sickle cell anemia,” American Journal of Hematology, vol. 91, no. 11, pp. 1118–1122, 2016. View at Publisher · View at Google Scholar
  18. J. C. Barrett, B. Fry, J. Maller, and M. J. Daly, “Haploview: analysis and visualization of LD and haplotype maps,” Bioinformatics, vol. 21, no. 2, pp. 263–265, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Stadhouders, S. Aktuna, S. Thongjuea et al., “HBS1L-MYB intergenic variants modulate fetal hemoglobin via long-range MYB enhancers,” The Journal of Clinical Investigation, vol. 124, no. 4, pp. 1699–1710, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. S. L. Thein, S. Menzel, M. Lathrop, and C. Garner, “Control of fetal hemoglobin: new insights emerging from genomics and clinical implications,” Human Molecular Genetics, vol. 18, no. 2, pp. R216–R223, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. G. F. Atweh and D. Loukopoulos, “Pharmacological induction of fetal hemoglobin in sickle cell disease and β-thalassemia,” Seminars in Hematology, vol. 38, no. 4, pp. 367–373, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Lettre, V. G. Sankaran, M. A. C. Bezerra et al., “DNA polymorphisms at the BCL11A, HBS1L-MYB, and β-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 33, pp. 11869–11874, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. L. E. Creary, P. Ulug, S. Menzel et al., “Genetic variation on chromosome 6 influences F cell levels in healthy individuals of African descent and HbF levels in sickle cell patients,” PLoS ONE, vol. 4, no. 1, Article ID e4218, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. T. K. T. Nguyen, P. Joly, C. Bardel, M. Moulsma, N. Bonello-Palot, and A. Francina Alain, “The XmnI Gγ polymorphism influences hemoglobin F synthesis contrary to BCL11A and HBS1L-MYB SNPs in a cohort of 57 β-thalassemia intermedia patients,” Blood Cells, Molecules, and Diseases, vol. 45, no. 2, pp. 124–127, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Makani, S. Menzel, S. Nkya et al., “Genetics of fetal hemoglobin in Tanzanian and British patients with sickle cell anemia,” Blood, vol. 117, no. 4, pp. 1390–1392, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. J. J. Farrell, R. M. Sherva, Z.-Y. Chen et al., “A 3-bp deletion in the HBS1L-MYB intergenic region on chromosome 6q23 is associated with HbF expression,” Blood, vol. 117, no. 18, pp. 4935–4945, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. G. L. Cardoso, I. G. Diniz, A. N. L. Martins da Silva et al., “DNA polymorphisms at BCL11A, HBS1L-MYB and Xmn1-HBG2 site loci associated with fetal hemoglobin levels in sickle cell anemia patients from Northern Brazil,” Blood Cells, Molecules, and Diseases, vol. 53, no. 4, pp. 176–179, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Pereira, L. Relvas, C. Bento, A. Abade, M. L. Ribeiro, and L. Manco, “Polymorphic variations influencing fetal hemoglobin levels: association study in beta-thalassemia carriers and in normal individuals of Portuguese origin,” Blood Cells, Molecules, and Diseases, vol. 54, no. 4, pp. 315–320, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Menzel, C. Garner, I. Gut et al., “A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15,” Nature Genetics, vol. 39, no. 10, pp. 1197–1199, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. A. E. Sedgewick, N. Timofeev, P. Sebastiani et al., “BCL11Ais a major HbF quantitative trait locus in three different populations with β-hemoglobinopathies,” Blood Cells, Molecules, and Diseases, vol. 41, no. 3, pp. 255–258, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. He, P. Chen, W. Lin, and J. Luo, “Analysis of rs4671393 polymorphism in hemoglobin E/β-thalassemia major in guangxi province of China,” Journal of Pediatric Hematology/Oncology, vol. 34, no. 4, pp. 323–324, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. S. L. Thein, J. S. Wainscoat, M. Sampietro et al., “Association of thalassaemia intermedia with a beta-globin gene haplotype,” British Journal of Haematology, vol. 65, no. 3, pp. 367–373, 1987. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Fucharoen, N. Siritanaratkul, P. Winichagoon et al., “Hydroxyurea increases hemoglobin F levels and improves the effectiveness of erythropoiesis in β-thalassemia/hemoglobin E disease,” Blood, vol. 87, no. 3, pp. 887–892, 1996. View at Google Scholar · View at Scopus
  34. G. V. Dedoussis, G. D. Mandilara, M. Boussiu et al., “HbF production in beta thalassaemia heterozygotes for the IVS-II-1 G–>A beta(0)-globin mutation Implication of the haplotype and the (G) gamma-158 C–>T mutation on the HbF level,” American Journal of Hematology, vol. 64, no. 3, pp. 151–155, 2000. View at Google Scholar
  35. M. Alebouyeh, F. Moussavi, H. Haddad-Deylami, and P. Vossough, “Hydroxyurea in the treatment of major β-thalassemia and importance of genetic screening,” Annals of Hematology, vol. 83, no. 7, pp. 430–433, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. N. F. Olivieri, G. M. Muraca, A. O'Donnell, A. Premawardhena, C. Fisher, and D. J. Weatherall, “Studies in haemoglobin E beta-thalassaemia,” British Journal of Haematology, vol. 141, no. 3, pp. 388–397, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. L. Nuntakarn, S. Fucharoen, G. Fucharoen, K. Sanchaisuriya, A. Jetsrisuparb, and S. Wiangnon, “Molecular, hematological and clinical aspects of thalassemia major and thalassemia intermedia associated with Hb E-β-thalassemia in Northeast Thailand,” Blood Cells, Molecules, and Diseases, vol. 42, no. 1, pp. 32–35, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. P. Dabke, R. Colah, K. Ghosh, and A. Nadkarni, “Effect of cis acting potential regulators in the β globin gene cluster on the production of HbF in thalassemia patients,” The Mediterranean Journal of Hematology and Infectious Diseases, vol. 5, no. 1, Article ID e2013012, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. D. E. Bauer, S. C. Kamran, S. Lessard et al., “An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level,” Science, vol. 342, no. 6155, pp. 253–257, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. P. Sebastiani, J. J. Farrell, A. Alsultan et al., “BCL11A enhancer haplotypes and fetal hemoglobin in sickle cell anemia,” Blood Cells, Molecules, and Diseases, vol. 54, no. 3, pp. 224–230, 2015. View at Publisher · View at Google Scholar · View at Scopus